Placemark Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$9.7M Buy
60,896
+33,812
+125% +$5.27M 0.17% 139
2014
Q3
$3.8M Buy
27,084
+6,499
+32% +$849K 0.07% 335
2014
Q2
$2.44M Sell
20,585
-11,315
-35% -$1.31M 0.04% 497
2014
Q1
$3.94M Sell
31,900
-6,319
-17% -$766K 0.08% 309
2013
Q4
$4.36M Buy
38,219
+10,526
+38% +$1.2M 0.07% 325
2013
Q3
$3.1M Sell
27,693
-6,539
-19% -$709K 0.06% 376
2013
Q2
$3.38M Buy
+34,232
New +$3.55M 0.07% 331

Other funds holding AMGN

Placemark Investments's AMGN Position: Q4 2014 in Review

Placemark Investments increased its Amgen (AMGN) stake by 125% in Q4 2014, buying an estimated $5.27M and bringing the position to 60,896 shares worth $9.7M. The position accounts for 0.17% of the portfolio, ranked #139.

Placemark Investments first reported a position in AMGN in Q2 2013 and has held it in 7 quarters since. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Placemark Investments held 60,896 shares of Amgen worth $9.7M as of Q4 2014.
  • Placemark Investments bought 33,812 Amgen shares in Q4 2014, an estimated $5.27M.
  • Amgen made up 0.17% of Placemark Investments's portfolio in Q4 2014, its #139 holding.
  • Placemark Investments first reported a position in Amgen in Q2 2013 and has held it in 7 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.